Atom | Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)

Due Dates: February 16, 2025 (New) | March 16, 2025 (Renewal/Resubmission/Revision) | May 8, 2025 (Expiration)

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; project period max 2 years.

Summary: Supports innovative epidemiologic research on emerging biological, environmental, and social risk factors for liver cancer susceptibility in the U.S., beyond established risks like viral hepatitis.

Key Information: Clinical trials are not allowed; applications focused solely on viral hepatitis or cohort infrastructure are non-responsive.

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)

Sign in to see full grant listing